RESLIZUMAB

UNII: 35A26E427H
Preferred Substance Name: RESLIZUMAB

241473-69-8
CEP-38072
CINQAIR
DCP 835
DCP-835
IMMUNOGLOBULIN G4, ANTI-(HUMAN INTERLEUKIN 5) (HUMAN-RAT MONOCLONAL SCH 55700 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL SCH 55700 LIGHT CHAIN, DIMER
MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)
RESLIZUMAB [INN]
RESLIZUMAB [MI]
RESLIZUMAB [PURPLE BOOK CDER]
RESLIZUMAB [USAN]
RESLIZUMAB [WHO-DD]
SCH55700
SCH-55700

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

RESLIZUMAB

Synonyms and Mappings

Resources

Note